On black skin, psoriasis plaques typically appear violet, purplish, or dark brown rather than the pink or red most people associate with the condition. The scales that form on top of these plaques tend to look gray instead of silvery white. These color differences can make psoriasis harder to spot, harder to diagnose, and harder to assess for severity, which is why knowing what to look for matters.
How Plaques Look on Dark Skin
The classic textbook image of psoriasis is a raised, red patch covered in silvery-white scales. That description is based almost entirely on how the condition presents on lighter skin. On black skin, the underlying redness is masked by melanin, so plaques take on a violet, dusky purple, or grayish-brown tone instead. In very deep skin tones, plaques can appear dark brown and blend into surrounding skin, making them easy to miss entirely.
The scales themselves also look different. Rather than bright silvery white, they often appear gray or muted. The patches still feel the same: raised, rough, and sometimes itchy or painful. They still favor the same areas, including elbows, knees, lower back, and the scalp. But the visual cues that most online resources describe simply don’t match what you’ll see on darker skin.
Guttate Psoriasis on Dark Skin
Guttate psoriasis shows up as small, drop-shaped spots, usually smaller than a pea, scattered suddenly across the back, arms, and thighs. It’s most common in children and young adults, often triggered by a recent infection like strep throat. On dark skin, these spots appear as darker brown or violet bumps rather than the pink dots described in most references. Because they’re small and can blend with natural skin tone variations, they’re sometimes dismissed as bug bites or a mild rash.
Scalp Psoriasis and Hair Loss
Scalp psoriasis is common across all skin tones, but it can be particularly concerning for Black patients because of the way it interacts with hair. Thick plaques form on the scalp and along the hairline, causing temporary hair loss in the affected areas. The hair typically regrows once the flare clears, but the thicker the plaque, the longer it may take. Depending on plaque thickness, stronger prescription treatments may be needed to fully clear the scalp, though this isn’t unique to darker skin tones.
For people who wear protective styles, braids, or extensions, scalp psoriasis can complicate hair care routines and make flares harder to treat with topical products. Flaking from scalp psoriasis can also be visually prominent against dark hair, which adds to the burden.
Why Psoriasis Gets Misdiagnosed on Black Skin
Because psoriasis on dark skin doesn’t look “classic,” it’s frequently confused with other conditions. The most common lookalikes include lichen planus (especially the thickened, raised type), discoid lupus, and sarcoidosis. In very deep skin tones, distinguishing between these conditions based on appearance alone can be difficult enough that a skin biopsy is needed to confirm the diagnosis.
The tools doctors use to measure psoriasis severity also contribute to the problem. The standard scoring system relies heavily on redness as a marker of inflammation. On dark skin, redness is much harder to see, and studies have shown that redness is the least reliably scored component when assessing psoriasis across different skin tones. This means the severity of psoriasis in Black patients can be systematically underestimated, potentially leading to less aggressive treatment than what’s actually needed.
Dark Spots That Linger After Plaques Clear
One of the most frustrating aspects of psoriasis on dark skin is what happens after a flare resolves. Even when plaques are successfully treated, they often leave behind dark marks called post-inflammatory hyperpigmentation. This happens because the inflammation from the plaque activates melanin-producing cells, which deposit extra pigment into the skin. People with darker skin are especially prone to this because their melanin-producing cells are larger, more active, and transfer more pigment to surrounding skin during inflammation.
These dark spots are not scars, but they can take a very long time to fade. Research on post-inflammatory hyperpigmentation across skin conditions found that the average duration before patients sought treatment was about 21 months, and resolution can take months to years. In some cases, the discoloration is permanent. For many Black patients, these lingering marks are just as distressing as the psoriasis itself, and managing them becomes a separate concern on top of controlling flares.
Treatment Considerations for Darker Skin
Most psoriasis treatments work the same regardless of skin tone. Topical creams, oral medications, and biologic therapies are all effective across the spectrum. But one common treatment, phototherapy (UV light therapy), comes with specific considerations for darker skin.
Narrowband UVB phototherapy can cause noticeable tanning in all exposed areas, and this effect is more pronounced in people with brown or dark skin, who naturally tan more readily. The resulting uneven pigmentation, where treated areas darken more than surrounding skin, is a significant quality-of-life concern. Studies have found that tanning from phototherapy negatively affects treatment compliance in dark-skinned patients, meaning some people stop treatment early because the cosmetic side effects feel worse than the psoriasis itself. The extra pigmentation can persist for weeks to months after treatment ends.
If phototherapy is recommended, it helps to know upfront that tanning will occur in all exposed skin and to discuss strategies for minimizing uneven tone, such as covering unaffected areas during sessions.
Prevalence in Black Americans
Psoriasis affects roughly 1.5% of non-Hispanic Black adults in the United States, compared to higher rates in white populations. The lower prevalence may partly explain why psoriasis on dark skin is underrepresented in medical training and educational materials. But lower prevalence doesn’t mean rare. Millions of Black Americans live with psoriasis, and the combination of diagnostic challenges, severity underestimation, and post-inflammatory pigment changes means the condition often carries a heavier burden than the numbers alone suggest.